GGrantIndex
← Leaderboards

Kishore M Gadde

Duke University

$5,984,050
Attributed
$5,984,050
Total exposure
4
Grants
3
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $693.1K · FY200525
$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$5,984,050 · 4

By mechanism

R01$4,211,225 · 2
U01$1,669,065 · 1
M01$103,760 · 1

Top collaborators

No co-investigators on record.

Most similar at Duke University

Same institution · by research overlap

Others in their field

Top investigators on “Pharmaceutical Preparations

Research focus

Pharmaceutical PreparationsPlacebosPharmacotherapyFollow-UpLife StylePrevalenceRandomizedQuality Of LifeRisk FactorsMetabolicBaseLipidsAtherosclerosisAffectLongitudinal StudiesDiabetes PreventionMeasurableMetforminCardiovascular Disorder RiskHealth EconomicsGlycosylated Hemoglobin AIntervention EffectCostHuman Disease

Grant awards (20)

Pharmacotherapy in conjunction with lifestyle counseling for management of weight regain after bariatric surgery (PROJECT-BARI)$693,106
R01 · FY2025 · DK · contact PI
Pharmacotherapy in conjunction with lifestyle counseling for management of weight regain after bariatric surgery (PROJECT-BARI)$692,938
R01 · FY2023 · DK · contact PI
Pharmacotherapy in conjunction with lifestyle counseling for management of weight regain after bariatric surgery (PROJECT-BARI)$647,702
R01 · FY2022 · DK · contact PI
Pharmacotherapy in conjunction with lifestyle counseling for management of weight regain after bariatric surgery (PROJECT-BARI)$667,445
R01 · FY2021 · DK · contact PI
1/22 Limited Competition for the Continuation of the Diabetes Prevention Program Outcomes Study (DPPOS) - Clinical Center$1
U01 · FY2021 · DK · contact PI
01/22 Diabetes Prevention Program Outcomes Study (DPPOS) Phase 3 - Research Project$237,247
U01 · FY2020 · DK · contact PI
01/22 Diabetes Prevention Program Outcomes Study (DPPOS) Phase 3 - Research Project$274,664
U01 · FY2019 · DK · contact PI
01/22 Diabetes Prevention Program Outcomes Study (DPPOS) Phase 3 - Research Project$283,410
U01 · FY2018 · DK · contact PI
01/22 Diabetes Prevention Program Outcomes Study (DPPOS) Phase 3 - Research Project$318,993
U01 · FY2017 · DK · contact PI
01/22 Diabetes Prevention Program Outcomes Study (DPPOS) Phase 3 - Research Project$222,000
U01 · FY2016 · DK · contact PI
01/22 Diabetes Prevention Program Outcomes Study (DPPOS) Phase 3 - Research Project$56,240
U01 · FY2016 · DK · contact PI
01/22 Diabetes Prevention Program Outcomes Study (DPPOS) Phase 3 - Research Project$29,997
U01 · FY2016 · DK · contact PI
DPPOS Follow-up$246,513
U01 · FY2015 · DK · contact PI
Zonisamide for Weight Reduction in Obese Adults$293,355
R01 · FY2009 · DK · contact PI
Zonisamide for Weight Reduction in Obese Adults$293,355
R01 · FY2008 · DK · contact PI
Zonisamide for Weight Reduction in Obese Adults$299,342
R01 · FY2007 · DK · contact PI
Zonisamide for Weight Reduction in Obese Adults$308,282
R01 · FY2006 · DK · contact PI
Zonisamide for Weight Reduction in Obese Adults$315,700
R01 · FY2005 · DK
MONOAMINE DEPLETION IN VASCULAR DEPRESSION$25,106
M01 · FY2005 · RR
Monoamine Depletion in Vascular Depression$78,654
M01 · FY2004 · RR